Literature DB >> 9660109

Abnormal persistence of cerebellar serotonin-1A receptors in schizophrenia suggests failure to regress in neonates.

P Slater1, C A Doyle, J F Deakin.   

Abstract

This study investigated the neurodevelopmental basis of schizophrenia by examining an early transient population of serotonin-1A (5-HT1A) receptors using quantitative [3H]8-OH-DPAT autoradiography on sections of frozen postmortem cerebellum. Production of an ontogenetic map showed that human neonatal cerebellum acquired dense 5-HT1A receptors, most of which were eliminated by early childhood. Autoradiographic measurements on cerebellar vermis from 16 control adult subjects confirmed sparse 5-HT1A receptor binding. The data show a persistence of some vermal 5-HT1A receptors in brains from 19 adults with chronic schizophrenia in whom there may have been a slowed or arrested postnatal regression of vermal 5-HT1A receptors. Alternatively, some 5-HT1A receptors may have been re-expressed prior to, or subsequent to, the onset of the disease symptoms. The findings are not obviously explained by drug treatment and there are no data to explain how neuroleptics might promote expression of cerebellar 5-HT1A receptors. We propose that the study has identified a neurotransmitter receptor population which, in schizophrenia, undergoes misdirected reshaping during brain development. The findings support neurodevelopmental hypotheses of the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660109     DOI: 10.1007/s007020050060

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  9 in total

Review 1.  The role of the cerebellum in schizophrenia.

Authors:  Nancy C Andreasen; Ronald Pierson
Journal:  Biol Psychiatry       Date:  2008-04-08       Impact factor: 13.382

2.  Cerebellar heterogeneity and its impact on PET data quantification of 5-HT receptor radioligands.

Authors:  Melanie Ganz; Ling Feng; Hanne Demant Hansen; Vincent Beliveau; Claus Svarer; Gitte M Knudsen; Douglas N Greve
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-11       Impact factor: 6.200

3.  Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635.

Authors:  W Gordon Frankle; Ilise Lombardo; Lawrence S Kegeles; Mark Slifstein; John H Martin; Yiyun Huang; Dah-Ren Hwang; Elisa Reich; Claudine Cangiano; Roberto Gil; Marc Laruelle; Anissa Abi-Dargham
Journal:  Psychopharmacology (Berl)       Date:  2006-09-05       Impact factor: 4.530

4.  Serotonergic control of Purkinje cell maturation and climbing fibre elimination by 5-HT3 receptors in the juvenile mouse cerebellum.

Authors:  Marlies Oostland; M Renate Buijink; Johannes A van Hooft
Journal:  J Physiol       Date:  2013-01-14       Impact factor: 5.182

5.  Cellular consequences of stress and depression.

Authors:  Eberhard Fuchs; Gabriele Flügge
Journal:  Dialogues Clin Neurosci       Date:  2004-06       Impact factor: 5.986

6.  Distinct temporal expression of 5-HT(1A) and 5-HT(2A) receptors on cerebellar granule cells in mice.

Authors:  Marlies Oostland; M Renate Buijink; Guus M Teunisse; Lars von Oerthel; Marten P Smidt; Johannes A van Hooft
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

Review 7.  Modulation, Plasticity and Pathophysiology of the Parallel Fiber-Purkinje Cell Synapse.

Authors:  Eriola Hoxha; Filippo Tempia; Pellegrino Lippiello; Maria Concetta Miniaci
Journal:  Front Synaptic Neurosci       Date:  2016-11-03

Review 8.  Towards in vivo imaging of functionally active 5-HT1A receptors in schizophrenia: concepts and challenges.

Authors:  Oriane Razakarivony; Adrian Newman-Tancredi; Luc Zimmer
Journal:  Transl Psychiatry       Date:  2021-01-07       Impact factor: 6.222

9.  Women with multiple chemical sensitivity have increased harm avoidance and reduced 5-HT(1A) receptor binding potential in the anterior cingulate and amygdala.

Authors:  Lena Hillert; Hristina Jovanovic; Fredrik Åhs; Ivanka Savic
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.